DocGo (DCGO) to Release Quarterly Earnings on Thursday

DocGo (NASDAQ:DCGO) is expected to announce its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of ($0.09) per share for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, February 27, 2026 at 4:00 PM ET.

DocGo Stock Up 2.1%

NASDAQ:DCGO opened at $0.81 on Thursday. The firm has a market capitalization of $79.49 million, a P/E ratio of -1.56 and a beta of 0.95. The company has a fifty day moving average of $0.84 and a 200-day moving average of $1.14. DocGo has a twelve month low of $0.66 and a twelve month high of $5.53.

Wall Street Analyst Weigh In

DCGO has been the topic of several recent research reports. Zacks Research upgraded DocGo from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Finally, Canaccord Genuity Group decreased their price target on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $3.21.

Institutional Investors Weigh In On DocGo

Institutional investors have recently bought and sold shares of the stock. Boothbay Fund Management LLC lifted its holdings in DocGo by 39.0% during the fourth quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock valued at $176,000 after purchasing an additional 56,413 shares during the last quarter. Squarepoint Ops LLC lifted its stake in shares of DocGo by 246.3% during the 4th quarter. Squarepoint Ops LLC now owns 94,511 shares of the company’s stock valued at $83,000 after buying an additional 67,216 shares in the last quarter. Wells Fargo & Company MN lifted its stake in shares of DocGo by 44.3% during the 4th quarter. Wells Fargo & Company MN now owns 100,811 shares of the company’s stock valued at $88,000 after buying an additional 30,957 shares in the last quarter. Empowered Funds LLC boosted its holdings in DocGo by 14.6% in the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock worth $121,000 after buying an additional 17,607 shares during the period. Finally, Voleon Capital Management LP purchased a new position in DocGo in the 3rd quarter valued at approximately $195,000. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.